The overall goal of our study was to assess whether: (1) MD simulations are able to differentiate between the normal and sickle Hb despite only a single amino acid substitution in a manner that is consistent with disease, and (2) the human and sheep variants behave similarly enough to support the development of a sheep model for the study of SCD. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.